Dr Reddys acquires cardiovascular drug Cidmus in India from Novartis AG
By, Admin1 min read
Share
Hyderabad-based drug major Dr Reddy's Laboratories Limited has entered into an agreement with Novartis AG to acquire the latter's cardiovascular brand Cidmus in India.
Under the agreement, Dr Reddy
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
